Carboplatin-Taxol-Bevacizumab Scheme
Jump to navigation
Jump to search
| Carboplatin-Taxol-Bevacizumab Scheme | |
|---|---|
| Term | Carboplatin-Taxol-Bevacizumab Scheme |
| Short definition | Carboplatin-Taxol-Bevacizumab Scheme - (pronounced) (KAR-boh-platin-TAK-sol-beh-vuh-SIH-zoo-mab REH-jih-men) chemotherapy combination for the treatment of advanced non-squamous non-small cell lung cancer. It includes the drugs carboplatin, paclitaxel (Taxol), and bevacizumab. |
| Type | Cancer terms |
| Specialty | Oncology |
| Language | English |
| Source | NCI |
| Comments | |
Carboplatin-Taxol-Bevacizumab Scheme - (pronounced) (KAR-boh-platin-TAK-sol-beh-vuh-SIH-zoo-mab REH-jih-men) chemotherapy combination for the treatment of advanced non-squamous non-small cell lung cancer. It includes the drugs carboplatin, paclitaxel (Taxol), and bevacizumab. Also called carboplatin-paclitaxel-bevacizumab regimen
External links
- Medical encyclopedia article on Carboplatin-Taxol-Bevacizumab Scheme
- Wikipedia's article - Carboplatin-Taxol-Bevacizumab Scheme
This MedicineGPT article is a stub. You can help make it a full article.
Languages: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
Urdu,
বাংলা,
తెలుగు,
தமிழ்,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
European
español,
Deutsch,
français,
русский,
português do Brasil,
Italian,
polski